TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
MicroPort NeuroTech Limited ( (HK:2172) ) has provided an announcement.
MicroPort NeuroTech Limited has announced changes in its board of directors, with Dr. Chang Zhaohua and Mr. Sun Qingwei resigning from their roles as non-executive directors and chairman of the board to focus on other business endeavors. Dr. Zhang Jie has been appointed as the new chairman and non-executive director, bringing extensive experience in research and development, particularly in the creation of the Firehawk Stent and securing numerous patents. Additionally, Mr. Liu Xudong has joined as a non-executive director, bringing significant marketing expertise from his previous roles in the healthcare sector. These changes are expected to strengthen the company’s leadership and continue its focus on innovation and market expansion.
The most recent analyst rating on (HK:2172) stock is a Hold with a HK$12.00 price target. To see the full list of analyst forecasts on MicroPort NeuroTech Limited stock, see the HK:2172 Stock Forecast page.
More about MicroPort NeuroTech Limited
MicroPort NeuroTech Limited is a company operating in the healthcare industry, focusing on innovative medical technologies. The company is involved in the development and commercialization of products across various medical fields, including ophthalmology, otorhinolaryngology, dentistry, and medical cosmetology.
Average Trading Volume: 6,087,701
Technical Sentiment Signal: Hold
Current Market Cap: HK$6.89B
Find detailed analytics on 2172 stock on TipRanks’ Stock Analysis page.